Vanda Pharmaceuticals Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $0.05 | $0.06 | $0.05 |
| Q2 2024 | 1 | -$0.21 | -$0.17 | -$0.19 |
| Q3 2024 | 1 | -$0.18 | -$0.14 | -$0.16 |
| Q4 2024 | 2 | -$0.10 | -$0.10 | -$0.10 |
| Q1 2025 | 2 | -$0.02 | -$0.02 | -$0.02 |
| Q2 2025 | 1 | $0.02 | $0.02 | $0.02 |
| Q3 2025 | 1 | $0.07 | $0.08 | $0.07 |
| Q4 2025 | 1 | $0.08 | $0.10 | $0.09 |
Vanda Pharmaceuticals Inc. Earnings Date And Information
Vanda Pharmaceuticals Inc. last posted its earnings results on Wednesday, November 6th, 2024. The company reported $-0.09 earnings per share for the quarter, topping analysts' consensus estimates of $-0.17 by $0.08. The company had revenue of 47.65 M for the quarter and had revenue of 192.64 M for the year. Vanda Pharmaceuticals Inc. has generated $0 earnings per share over the last year ($0.0436 diluted earnings per share) and currently has a price-to-earnings ratio of -18.1. Vanda Pharmaceuticals Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 5th, 2025 based on prior year's report dates.
Vanda Pharmaceuticals Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.09 | $49.17 M | $47.65 M | ||
| 08/01/2024 | Q2 2024 | -$0.08 | $47.90 M | $50.47 M | ||
| 05/09/2024 | Q1 2024 | -$0.07 | $47.46 M | |||
| 02/08/2024 | Q4 2023 | -$0.04 | $45.27 M | |||
| 11/09/2023 | Q3 2023 | $0.00 | $44.50 M | $38.82 M | ||
| 07/28/2023 | Q2 2023 | $0.03 | $49.00 M | $46.06 M | ||
| 05/03/2023 | Q1 2023 | $0.06 | $62.50 M | |||
| 02/09/2023 | Q4 2022 | $0.12 | $64.48 M | |||
| 11/03/2022 | Q3 2022 | $0.06 | $71.00 M | $65.32 M | ||
| 08/04/2022 | Q2 2022 | $0.05 | $67.00 M | $64.39 M | ||
| 05/06/2022 | Q1 2022 | -$0.11 | $60.19 M | |||
| 02/24/2022 | Q4 2021 | $0.13 | $68.02 M | |||
| 11/04/2021 | Q3 2021 | $0.14 | $74.25 M | $70.10 M | ||
| 07/29/2021 | Q2 2021 | $0.17 | $69.75 M | $67.90 M | ||
| 05/06/2021 | Q1 2021 | $0.16 | $62.67 M | |||
| 02/11/2021 | Q4 2020 | $0.15 | $67.65 M | |||
| 10/29/2020 | Q3 2020 | $0.11 | $64.20 M | $60.31 M | ||
| 08/06/2020 | Q2 2020 | $0.16 | $61.95 M | $62.21 M | ||
| 05/07/2020 | Q1 2020 | $0.01 | $58.00 M | |||
| 02/26/2020 | Q4 2019 | $0.08 | $60.93 M |
Vanda Pharmaceuticals Inc. Earnings: Frequently Asked Questions
-
When is Vanda Pharmaceuticals Inc.'s earnings date?
Vanda Pharmaceuticals Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 5th, 2025 based off last year's report dates.
-
Did Vanda Pharmaceuticals Inc. beat their earnings estimates last quarter?
In the previous quarter, Vanda Pharmaceuticals Inc. (:VNDA) reported $-0.09 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.17 by $0.08.
-
How can I listen to Vanda Pharmaceuticals Inc.'s earnings conference call?
The conference call for Vanda Pharmaceuticals Inc.'s latest earnings report can be listened to online.
-
How can I read Vanda Pharmaceuticals Inc.'s conference call transcript?
The conference call transcript for Vanda Pharmaceuticals Inc.'s latest earnings report can be read online.
-
How much revenue does Vanda Pharmaceuticals Inc. generate each year?
Vanda Pharmaceuticals Inc. (:VNDA) has a recorded annual revenue of $192.64 M.
-
How much profit does Vanda Pharmaceuticals Inc. generate each year?
Vanda Pharmaceuticals Inc. (:VNDA) has a recorded net income of $192.64 M. Vanda Pharmaceuticals Inc. has generated $0.0437 earnings per share over the last four quarters.
-
What is Vanda Pharmaceuticals Inc.'s price-to-earnings ratio?
Vanda Pharmaceuticals Inc. (:VNDA) has a price-to-earnings ratio of -18.1 and price/earnings-to-growth ratio is 0.38.
